Download PDF
1 / Pages

Other users also viewed these articles

Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents Diego García-Compeán; Ramesh Kumar; Ángel Noe del Cueto-Aguilera; Héctor Jesús Maldonado-Garza; Jesús Zacarías Villarreal-Pérez;
Ann Hepatol. 2023;28:
Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? Diego García-Compeán; Jesús Zacarías Villarreal-Pérez; Manuel Enrique de la O. Cavazos; Fernando Javier Lavalle-Gonzalez; Omar David Borjas-Almaguer; Angel Noé Del Cueto-Aguilera; José Alberto González-González; Consuelo Treviño-Garza; Lourdes Huerta-Pérez; Héctor Jesús Maldonado-Garza;
Ann Hepatol. 2020;19:258-64
Palliative care and end stage liver disease: A cohort analysis of palliative care use and factors associated with referral Hugo M Oliveira; Helena Pessegueiro Miranda; Francisca Rego; Rui Nunes;
10.1016/j.aohep.2024.101518